biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Comment by Yoshitoshion Mar 13, 2013 4:33pm

165 Views

Post# 21124956

RE: technicals ...

thanks for the great insight Sinbob... makes alot of sense to me... Shire has had enough time now kicking the can down the street and as far as i'm concerned... they can HIT THE ROAD... come back some other day... or not... by then BTI will have been taken seriously by another pharma... or two or three... that has the time... and the market cap will be much higher imho

Bullboard Posts

Global Tungsten Market and Supply Security